Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
JAMA Netw Open
; 3(10): e2020425, 2020 10 01.
Article
em En
| MEDLINE
| ID: mdl-33074326
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxaloacetatos
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias do Colo
/
Capecitabina
/
Bevacizumab
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article